Versant Venture Capital VI, L.P.
Versant Venture Capital VI, L.P.'s open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares…
Insider buying and selling since 2020
Versant Venture Capital VI, L.P. bought shares on the open market in 2020, and has not bought since 2020 across 5 companies. Sales in 3 of the 7 years since 2020.
Versant Venture Capital VI, L.P. reported 5 open-market purchases and 44 sales since 2020; purchases in 2020.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 28×28 trades |
| 2024 | — | 6×6 trades |
| 2020 | 5×5 trades | 10×10 trades |
Insider at 5 companies
- Lenz Therapeutics LENZ2025 · 0 purchases, 28 sales
- Monte Rosa Therapeutics GLUE2024 · 0 purchases, 4 sales
- Tempest Therapeutics TPST2024 · 0 purchases, 2 sales
- Black Diamond Therapeutics BDTX2020 · 4 purchases, 10 sales
- Aligos Therapeutics ALGS2020 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Versant Venture Capital VI, L.P.'s trades
Has Versant Venture Capital VI, L.P. bought shares on the open market?
Versant Venture Capital VI, L.P. bought shares on the open market in 2020, and has not bought since 2020 across 5 companies. Sales in 3 of the 7 years since 2020.
When did Versant Venture Capital VI, L.P. last buy or sell shares?
In SEC filings since 2020: the latest open-market purchase is from 2020; the latest open-market sale is from 2025.
Which companies has Versant Venture Capital VI, L.P. traded as an insider?
5 companies: Lenz Therapeutics (LENZ, 2025), Monte Rosa Therapeutics (GLUE, 2024), Tempest Therapeutics (TPST, 2024), Black Diamond Therapeutics (BDTX, 2020), Aligos Therapeutics (ALGS, 2020).